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ABSTRACT
Objective: The study of Mycoplasma gallisepticum (MG) infection is needed, not only to understand the disease process but also to understand the 
interference with the evaluation of some live viral poultry vaccines. This study aims to investigate the titration and potency of some live attenuated 
poultry viral vaccines; Newcastle disease, infectious bronchitis, infectious bursal disease, and Reo in both specific pathogen-free (SPF) embryonated 
chicken eggs (ECEs) and chickens.
Methods: Titration of live attenuated viral poultry vaccines in ECEs was carried out by dividing the inoculated eggs into four groups; the pre-, 
simultaneously-, post-, and non-MG contaminated. MG effect on the potency test was carried out using seventeen groups of SPF chickens (25 chicken/
group) placed into separate isolators. Each live attenuated viral poultry vaccine was inoculated into 4 groups.
Results: The highest titer of these vaccines that appeared in MG pre- contaminated ECEs were 1011, 107.5, 107.9, and 107.5, respectively. The lowest vaccine 
titers that appeared in non-MG contaminated ECEs were 108, 106, 106.8, and 106, respectively. Although the potency of these previous vaccines indicated that 
the highest antibodies titer that appeared in MG pre-infected vaccinated chickens were 7.5 log2, 36 enzyme-linked immunosorbent assay unit (EU), and 
42 EU, respectively; the lowest antibodies titer that appeared in non-MG infected vaccinated chickens were 6.5 log2, 12 EU, 17 EU, and 10 EU, respectively.
Conclusion: The present study findings underline the importance of using Mycoplasma -free eggs or chicken for the production of virus vaccines.
Keywords: Mycoplasma gallisepticum, Newcastle disease virus, Infectious bronchitis virus, Infectious bursal disease virus, Reo virus, Chicken, Specific 
pathogen-free eggs.
INTRODUCTION
One of the most important mycoplasmas isolated from domestic avian 
species is Mycoplasma gallisepticum (MG) [1]. MG causes chronic 
respiratory disease of chickens and infectious sinusitis in turkeys, 
resulting in economic losses. It is transmitted through the egg and is 
well-known for its interactions with other infectious agents [1].
Mycoplasmas, particularly species of the genera Mycoplasma, are 
frequent contaminants of vaccine substrates, that is, continuous cell 
lines, and less frequently, animal-derived tissues and primary cell 
cultures [2]. Mycoplasma may affect the cell-mediated immune system 
by inducing either suppression or stimulation of B and T lymphocytes 
and inducing cytokines [3].
Newcastle disease (ND), infectious bronchitis (IB), infectious bursal 
disease (IBD), and Reovirus strains can be categorized as velogenic 
(highly virulent) and mesogenic (intermediate virulence) [4]. These 
diseases were reported as the most important viral diseases of poultry 
in the world including developing countries [5-7]. ND virus strains 
are spread rapidly between bird flocks so vaccination is necessary 
and is routinely performed using live-virus vaccines against ND 
virus (lentogenic strain LaSota), which is commonly produced using 
embryonated chicken eggs (ECEs) [4]. So that, mixed infections involving 
Mycoplasma, viruses, and bacteria are well-recognized in chickens. 
Synergism has been demonstrated between MG and the viruses of ND 
and IB [8]. Both MG and ND virus are able to successfully propagate 
in ECEs. The chicken embryo could represent a model system for the 
analysis of consecutive Mycoplasma synoviae (MS) -lentogenic-ND virus 
co-infection that may occur after ND virus infection (e.g., vaccination) 
of MS-infected host. Co-infections with MS and different avian viruses, 
concerning clinical signs, have been described by Kleven [1] and 
Landman and Feberwee [9]. Moreover, Mycoplasma hyorhinis always 
occurs worldwide as a co-infection with other swine pathogens, such 
as porcine reproductive and respiratory syndrome virus or porcine 
circovirus-2 [10].
Avian IB infection may precipitate latent Mycoplasma infection. Many 
studies [11,12] emphasize the importance of using Mycoplasma-
free eggs for the production of virus vaccines. There was at least 
one hundred-fold increase in the multiplication of MG in eggs 
simultaneously or previously infected with avian IB virus (IBV) made 
by inoculation of eggs in the allantoic sacs of 10-day embryonated 
hen’ eggs [11].
When mildly virulent virus strains infect birds, which have already 
been infected with Mycoplasma, interactions between the host, 
Mycoplasma cells, and the virus may result in effects that differ from 
those which are expected after single pathogen infection [13]. Thus, 
severe inflammatory reactions and synergistic pathogen interactions 
can occur after vaccinations with live virus vaccines [13].
The current study aimed to clarify the effect of MG contamination in 
specific pathogen-free (SPF) eggs or infected chickens on virus titration 
and efficacy of some live attenuated viral poultry vaccines.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i1.14930
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METHODS
SPF eggs
Fertile SPF eggs were obtained from the national project for production 
of SPF eggs (Nile SPF eggs), Koom Oshiem, Fayoum, Egypt. Furthermore, 
they were hatched in the Central Laboratory for Evaluation of Veterinary 
Biologics (CLEVB), Cairo, Egypt.
Chickens
Four hundred forty-five of 14 days SPF chickens were obtained from 
the national project for production of SPF eggs (Nile SPF eggs), Koom 
Oshiem, Fayoum, Egypt.
MG strain and its growth media
MG strain was obtained from Animal Health Institute in Dokki, 
Mycoplasma department. This strain was propagated according to 
Naylor et al. [14]. The number of colony forming units (CFU) was 
determined by the standard procedures of Rodwell and Whitcomb [15] 
to obtain 106 CFU of MG strain to be inoculated in different groups of 
ECEs and chickens.
MG antigen and antiserum
MG colored antigens and chicken anti-MG sera were used for serum plate 
agglutination test (SPA). They were kindly obtained from Mycoplasma 
Department, Animal Health Research Institute, Dokki - Giza, Egypt.
Live attenuated viral poultry vaccines
Four types of live attenuated viral poultry vaccines (ND, IB, IBD, and Reo 
virus vaccines) were obtained from CLEVB. The vaccines were kept at 
refrigerator (4-8°C) till use.
Virus strains
Newcastle disease virus (NDV) strain genotype 7 accession 
No.KM288609, standard local viral strains of IB, IBD and Reo were 
obtained from Viral Strain Bank of CLEVB that used for challenge tests.
Experimental design
Titration of ND, IB, IBD, and reo live attenuated viral poultry 
vaccines in ECEs
The titration of ND vaccine
Ten-fold serial dilutions (10−1-10−12) of the vaccine were prepared in 
sterile saline with antibiotic. Of each dilution, 0.2 ml was inoculated in 
20 eggs via allantoic cavityper egg (in 9- to 11-day-old embryonated 
SPF chicken eggs according to Senne [16]. The inoculated eggs of each 
dilution were divided into four groups (pre-, simultaneously-, post-, and 
non-MG contaminated) as follow:
Group A (pre-MG contaminated): Five eggs inoculated with 0.2 ml of 
5×106 CFU of MG strain first at 7-day-old in yolk sac (intra-yolk route). 
Yolk sac inoculation procedure followed the procedure reviewed by 
Senne [16] and then at 9-day-old inoculated with NDV via allantoic cavity.
Group B (simultaneously-MG contaminated): Five eggs inoculated 
simultaneously by 0.2 ml of 5x106 CFU of MG strain with the vaccine.
Group C (post-MG contaminated): Five eggs inoculated with 0.2 ml of 
each dilution of NDV first at 9-day-old and then 0.2 ml of 5×106 CFU of 
MG strain via allantoic cavity.
Group D (non-MG contaminated): Five eggs per each dilution inoculated 
with 0.2 ml of NDV at 9-day-old via allantoic cavity.
The inoculated eggs were incubated at 37°C with 60% humidity and 
candled daily for 6 days later. Dead embryos (within 24 hrs) were 
discarded and considered non-specific. Then, any dead embryos after 
these 24 hrs were removed and kept in refrigerator at 4°C and recorded 
daily for calculation of the titer of the vaccine at the end of the sixth day 
and all remained eggs were put in refrigerator. Haemagglutination test 
(HI) was applied on the allantoic fluid of the inoculated eggs, and the 
positives were counted, and the titer was calculated [17].
The titration of IB vaccine
All previous steps of the previous experiment were applied with the 
exception that the vaccine of IB dilutions was from 10−1 to 10−8. In 
addition, the titer of vaccine was calculated according to criteria of 
embryo [17].
The titration of IBD and Reo vaccine
All previous steps used in the titration of IB vaccine were applied.
MG effect on the potency test for the evaluation of live attenuated 
viral poultry vaccines
Seventeen groups of SPF chickens (25 chicken/group) were placed 
into separate isolators. Each live attenuated viral poultry vaccine 
was inoculated into 4 groups as follows: Group 1 inoculated with MG 
at 14 days old SPF chickens 0.25 ml intranasally (i.n.) and 0.25 ml 
by subcutaneous (s.c.) route of 106 CFU of prepared MG then ND 
virus vaccine (NDVV) was inoculated. Group 2 inoculated with NDVV 
simultaneously with MG (0.25 ml i.n. and 0.25 ml s.c. route of 106 CFU of 
prepared MG. Group 3 inoculated with NDVV and then infected with MG 
0.25 ml i.n. and 0.25 ml by s.c. route of 106 CFU of prepared MG 5 days 
post vaccination. Group 4 inoculated with NDVV. Groups 1-4 were 
inoculated with NDVV according to recommend manufactured dose and 
route of vaccine at 21-day-old. Groups (5-8), (9-12), and (13-16) were 
vaccinated with IB, IBD, and Reo VV, respectively, as mentioned before 
in Groups 1-4. Group 17 was kept as control non-infected unvaccinated 
group.
MG re-isolation and identification
Re-isolation
The re-isolation of MG was done by taken egg yolk samples from the 
contaminated ECEs (pre-, simultaneous- and post-contamination). 
Swabs were taken from the eyes, nostrils, and pharyngeal of infected 
chickens (pre-, simultaneous- and post-infection). The egg yolk 
samples and different swabs were dipped into pleuropneumonia-like 
organisms (PPLO) broth medium (Difco Laboratories) to enhance 
isolation of Mycoplasma [18]. The cultured broth was incubated at 
37°C in CO2 incubator (10% CO2) for 48-72 hrs or until the color of the 
broth changed. After that loopful of the culture broth was placed on 
PPLO agar plate [19], incubate the plate at 37°C in CO2 incubator for 
5-7 days. The plate was examined daily under stereo-zone microscope 
for identification of fried egg colonies specific to Mycoplasma.
MG identification
Egg yolk and blood samples [20] were collected randomly from 
contaminated ECEs and infected chickens in pre, simultaneously and 
post groups, then egg yolk and serum samples were prepared for SPA 
test to ensure the presence of MG.
Egg yolk and blood samples collection and preparation
The egg yolk and serum preparation were done according to Office 
International Des Epizooties (OIE) [21].
Haemagglutination inhibition (HI) test
It was applied for calculating the titer of ND virus in the collected 
allantoic fluid of all inoculated groups of ECEs according to OIE [21]. 
All serum samples from Groups 1-4 were collected for estimation 
of antibody titers against ND virus using HI test [22]. The test was 
performed according to the procedure of OIE (2002). In brief, two-
fold serial dilution of 25 µl serum was made with phosphate-buffered 
saline (PBS) in V-bottomed microtiter plates (Nunc) up to 10th well. 
25 µl of 4 hemagglutinating (HA) units of virus or antigen was added 
up to 11th well. The plates were kept at room temperature for more 
than 30 minutes to facilitate antigen-antibody reaction. Then, 50 µl of 
1% (v/v) chicken red blood cells (RBCs) suspension was added to each 
well. The 11th well contains antigen and RBCs as the positive control, 
and the 12th well contains only RBCs as the negative control. After 
gentle mixing, the RBCs were allowed to settle at room temperature for 
40 minutes, and agglutination was assessed by tilting the plates. The 
samples showing peculiar central button shaped settling of RBCs were 
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recorded as positive and maximum dilution of each sample causing HI 
was considered the end point, which was used to estimate the HI titer. 
The HI titer of each serum sample was expressed as reciprocal of the 
serum dilution.
Enzyme-linked immunosorbent assay (ELISA)
It was conducted as described by Jordan et al. [23]. IBV AB ELISA kit was 
used for estimation of antibodies titers against IBV in serum samples 
collected from Groups 5 to 8.
AB ELISA kit calculated the antibodies titer against IBD virus (IBDV) in 
serum samples collected from Groups 9 to 12. While ReoV AB ELISA kit 
was used for estimation of antibodies titers against Reovirus in serum 
samples collected from Groups 13 to 16.
Challenge test
At 28 days post-vaccination, the vaccinated and control groups were 
challenged then kept under observation for 10-14 days post-challenge.
Chicken groups vaccinated by ND vaccine were challenged 
intramuscularly with a local virulent strain of ND virus containing at 
least 106 embryo lethal doses (ELD50)/bird [24].
Chicken groups vaccinated by IB and IBDV vaccine were challenged 
with a standard virulent strain of the virus of IB (M41 type) and IBD 
(52/70), respectively. Each bird received at least 103.5 ELD50 of challenge 
IBV virus intranasal. While each bird received at least 103 ELD50 of 
challenge IBDV virus by conjunctiva instillation.
Chicken groups vaccinated by Reo virus vaccine were challenged with 
a standard virulent strain of avian Reovirus strain S1133. Each bird 
received at least 103.5 EID50 of challenge Reovirus into the foot pad 
0.1 ml/chicken.
RESULTS
Mycoplasma re-isolation from ECEs and chicken swabs
All samples taken from egg yolk and swabs, from both contaminated 
eggs and infected chickens of pre-, simultaneous- and post-MG groups, 
were gave fried egg colonies, by examination under stereo-zone 
microscope. While samples obtained from non-MG contaminated and 
infected groups were not gave any colonies.
Mycoplasma identification by SPA test
All collected samples of egg yolk and serum samples from both 
contaminated eggs and infected chickens of pre-, simultaneous- and 
post-MG groups were gave clear agglutination by SPA test while there 
was any agglutination in samples obtained from non-MG contaminated 
and infected groups.
Titration of live attenuated vaccines in SPF-ECEs among 
MG-infected groups
Table 1 indicated that the highest titer of ND virus by HA test, applied on 
allantoic fluid of ECEs, was appeared in Mycoplasma pre-contaminated 
group (1011).
The lowest titers were recorded in Mycoplasma non-infected group 
(108). The highest titer of IBV was appeared in Mycoplasma pre-
contaminated group (107.5), whereas the lowest titers were recorded in 
IBV MG non-infected group (106).
The highest titer of IBDV was appeared in Mycoplasma pre-contaminated 
group (107.9), whereas the lowest titers were recorded in IBD inoculated 
without MG contamination group (106.8).
Finally, the highest titer of Reo virus was appeared in Mycoplasma pre-
contaminated group (107.5), whereas the lowest titers were recorded 
in Reo virus inoculated without MG contamination group (106). Fig. 1a 
shows normal embryos and Fig. 1b shows curling and dwarfism of 
inoculated embryos characteristic to IBV. Fig. 2a shows normal embryo 
liver and Fig. 2b shows yellowish-white discoloration of embryo liver 
indicated the characteristic lesion of IBDV. Fig. 3a shows normal 
embryo while Fig. 3b shows strawberry like embryos due to Reo virus 
inoculation.
Table 2 indicatesthat the highest titer of ND antibodies by HI test at the 
28 days post-inoculation was appeared in Mycoplasma pre-infected 
group (7.5 log2), whereas the lowest titers were recorded in NDV 
inoculated alone group (6.5 log2). The protection percentage against 
NDV revealed that the Mycoplasma pre-infected, ND challenged group 
was more protected group (100%) than simultaneously and post 
Mycoplasma infected group (95%) and the non-infected ND challenged 
group recorded lowest protection percent (90%). Fig. 4 illustrateds 
the postmortem lesions showed the presence of petechial hemorrhage 
all over mucous membranes of the proventriculus in challenged 
unvaccinated group that are characteristic to NDV. Fig. 5 represents SPF 
chickens showed nervous manifestations after challenged unvaccinated 
group with NDV.
The results in Table 3 recorded that the highest titer of IB antibodies by 
ELISA test on collected serum at the 28 days post inoculation of chickens 
was in Mycoplasma pre-infected group (36 ELISA unit [EU]) while the 
lowest titers were recorded in IB inoculated without MG-infected 
group (12 EU). The protection percentage against IBV revealing that 
the Mycoplasma pre-infected, IB challenged group was more protected 
group (100%) than simultaneously and post Mycoplasma-infected 
group (95%) and the non-infected IBV challenged group recorded 
lowest protection percent (90%).
The highest titer of IBD antibodies by ELISA test on collected serum 
at the 28 days post inoculation was in Mycoplasma pre-infected group 
(42 EU) while the lowest titers were recorded in IBD inoculated 
without MG-infected group (17 EU). The protection percentage 
against IBDV revealed that all MG-infected IBD challenged groups 
showed higher protection percentage (100%) than the MG non-
infected IBD challenged group that recorded (90%). The highest titer 
of Reo antibodies by ELISA test on collected serum at the 28 days post 
inoculation was in Mycoplasma pre-infected group (14 EU) while the 
lowest titers were recorded in Reo inoculated without MG-infected 
group (10 EU). The highest protection percentage against Reovirus 
was in Reo challenged MG (Pre- and simultaneously infected group 
(100%) while the MG non-infected Reo challenged group was the 
lowest protected group (90%). Fig. 6 have arrows refer to bronchioles 
containing caseous plugs in IBV challenged unvaccinated chicken 
which characteristics to IB disease. Fig. 7 shows SPF chicken have 
gasping of air in unvaccinated group challenged with IBV. Fig. 8a 
showskidneys of unvaccinated chicken affected by a severe urate 
diathesis due to challenge with IBDV while Fig. 8b shows enlarged 
Fig. 1: (a) Normal embryos, (b) Curling and dwarfism 
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bursa of fabricius with yellowish peribursal oedema in unvaccinated 
chicken challenged with IBDV. Fig. 8c shows hemorrhages on thigh 
muscles in unvaccinated chicken challenged with IBDV. Fig. 9 of SPF 
chicken shows severe diarrhea in unvaccinated group challenged 
with IBDV. In Fig. 10, the red rings showed malabsorption syndrome 
(characteristics to Reo disease) in proventriculus of unvaccinated 
chicken challenged with Reo virus. Fig. 11 illustrates the SPF chicken 
showed limpness associated with tenosynovitis in challenged 
unvaccinated group with Reo virus.
DISCUSSION
The current study investigated the effect of MG contamination to 
fertile SPF eggs and chickens on the titration and potency of some 
live attenuated poultry viral vaccines (ND, IB, IBD and Reo virus) 
was carried out. ECEs are among the most useful and available 
Fig. 3: (a) Normal embryo, (b) Strawberry like embryos due to 
Reo virus inoculation
Fig. 4: Postmortem lesions showed the presence of petechial 
haemorrhage all over mucous membranes of the proventriculus 
in challenged unvaccinated group which are characteristic to 
Newcastle disease virus
Fig. 5: Specific pathogen-free chickens showed nervous 
manifestations after challenged unvaccinated group with 
Newcastle disease virus
Fig. 6: Arrows refer to bronchioles containing caseous plugs in 
infectious bronchitis virus challenged unvaccinated chicken 
which characteristics to infectious bronchitis disease
Fig. 7: Specific pathogen-free chicken show gasping of air in 
unvaccinated group challenged with infectious bronchitis virus
forms of living animal tissue for the isolation and identification 
of viruses, for titrating viruses, and for quantity cultivation in the 
production of viral vaccines [25]. Therefore, inoculated ECEs with 
MG in three ways, pre-, simultaneously- and post- of the inoculated 
vaccines were chosen, in the current study. It is clear that MG 
inoculations enhance the replication of viruses and increase their 
titers in ECEs. These results are supported with Bolha et al. [26] 
who reported that when mildly virulent virus strains infect birds 
Fig. 2: (a) Normal embryo liver, (b) Yellowish-white discoloration 
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Table 1: Titration of live attenuated vaccines in SPF ECEs
Infected groups Vaccine
ND IB IBD Reo
Pre-MG 1011 107.5 107.9 107.5
Simultaneous-MG 109.5 107 107.2 107
Post-MG 1010 106.8 107 106.8
Non-MG 108 106 106.8 106
SPF: Specific pathogen-free, ECEs: Embryonated chicken eggs, MG: Mycoplasma 
gallisepticum, IBD: Infectious bursal disease, IB: Infectious bronchitis
Table 2: Antibody titers tested by HI test and protection percent among the vaccinated groups
Groups 14th PV 21th PV 28th PV Protection percent t-test
Sig. (two-tailed) SD
G1 5.4 log2 6.5 log2 7.5 log2 100 0.035 7.0000
G2 4.9 log2 6.2 log2 7.2 log2 95 0.012 1.17898
G3 4.5 log2 5.8 log2 6.8 log2 95 0.013 1.153256
G4 4.2 log2 5.5 log2 6.5 log2 90 0.015 1.153256
PV: Post-vaccination, G1: The infected with MG then vaccinated with Newcastle disease virus vaccine (NDVV), G2: The vaccinated with NDVV and simultaneously 
infected with MG, G3: The vaccinated with then infected with MG, G4: The vaccinated only with NDVV, Sig.: Significance (0.01-0.05), SD: Standard deviation, 
HI: Haemagglutination test, MG: Mycoplasma gallisepticum
Table 3: Antibody titers tested by ELISA and protection percent among the vaccinated groups
Groups 14th PV 21th PV 28th PV Protection percent* t-test
Sig. (two-tailed) SD
G5 25 EU 35 EU 36 EU 100 0.012 6.082763
G6 10 EU 15 EU 22 EU 95 0.046 6.027714
G7 8 EU 11 EU 14 EU 95 0.024 3.000000
G8 7 EU 10 EU 12 EU 90 0.022 2.516611
G9 18 EU 30 EU 42 EU 100 0.049 12.000000
G10 10 EU 19 EU 25 EU 100 0.054 7.549834
G11 9 EU 16 EU 20 EU 100 0.043 5.567764
G12 7 EU 12 EU 17EU 90 0.053 5.000000
G13 6 EU 11 EU 14 EU 100 0.047 4.041452
G14 6 EU 10 EU 12 EU 100 0.034 3.055050
G15 6 EU 10 EU 11 EU 95 0.028 2.645751
G16 4 EU 8 EU 10 EU 90 0.053 3.055050
PV: Post-vaccination, G5-8: Vaccinated with IB VV, G9-12: Vaccinated with IBD VV, G13-16: 20 Vaccinated with Reo VV, G5-16: They were vaccinated with virus vaccine as 
mentioned before in Groups 1-4; *: 6th days post challenge, EU: ELISA unit, Sig.: Significance (0.01-0.05), SD: Standard deviation, ELIZA: Enzyme-linked immunosorbent 
assay
that have already been infected with Mycoplasma, interactions 
between the host, Mycoplasma cells, and virus may result in effects 
that differ from those which are expected after single pathogen 
infection.
The present study depended on the fact that Mycoplasma can be 
transmitted vertically to eggs. MG seemed to play a role in increasing 
the titer of inoculated viruses (ND, IB, IBD, and Reo) in eggs that 
might be due to changing the pH of the egg content by the metabolite 
products of Mycoplasma obtained from its multiplication inside the egg 
[12]. MG can multiply on the chorioallantoic or allantoic sac despite its 
inoculation intra-yolk [27]. The two routes of egg inoculation (intra 
yolk and intra allantoic) for inoculation of ECEs were used in the 
current study.
Mixed infections involving Mycoplasma, viruses, and bacteria are well 
recognized in chickens. Synergism has been demonstrated between MG 
and the viruses of ND and IB and Escherichia coli [8].
The current study results showed the highest titer of ND virus by HA 
test, applied on allantoic fluid of ECEs, was appeared in Mycoplasma 
pre-contaminated group while the lowest titers were recorded in 
ND inoculated without MG contamination group. Co-infections were 
more severe than single infections [28]. Both MG and ND virus can 
successfully propagate in ECEs. The chicken embryo could represent a 
model system for the analysis of consecutive MS-lentogenic ND virus 
co-infection that may occur after the virus infection (e.g., vaccination) 
as concluded by Bolha et al. [26].
Fig. 8: (a) Kidneys of unvaccinated chicken affected by a severe urate diathesis due to challenge with infectious bursal disease virus 
(IBDV), (b) enlarged bursa of fabricius with yellowish peribursal oedema in unvaccinated chicken challenged with IBDV, (c) hemorrhages 
on thigh muscles in unvaccinated chicken challenged with infectious bursal disease virus
a b c
221
Asian J Pharm Clin Res, Vol 10, Issue 1, 2017, 216-222
 Fathy et al. 
Fig. 10: The red rings showed malabsorption syndrome (characteristics to Reo disease) in proventriculus of unvaccinated chicken 
challenged with Reo virus
Fig. 9: Specific pathogen-free chicken showed severe diarrhea in unvaccinated group challenged with infectious bursal disease virus
Fig. 11: Specific pathogen-free chicken show limpness associated 
with tenosynovitis in challenged unvaccinated group with Reo 
virus
Severity of clinical respiratory symptoms associated with MS, which 
exacerbated by co-infection with various respiratory viruses, such 
as ND and IB were reported Landman and Feberwee [9]. This is 
compatible with the present results, which revealed the highest titer of 
ND antibodies by HI test at the 28 days post-inoculation in Mycoplasma 
pre-infected group while the lowest titers were recorded in NDV 
inoculated alone.
The effect of MG on potency of IBV by was investigated by three ways 
(pre-, simultaneously- and post-vaccination). Inoculation the IB vaccine 
this following a part of the model of Landman and Feberwee [9], as 
clinical symptoms due to IBV were expected to peak. Hopkins and 
Yoder [29] suggested that chicken-passage mild IB vaccine virus 
markedly increased the incidence of airsacculitis compared with non-
passage vaccine virus so that chickens vaccinated with IB vaccine have 
higher AB titer and more protected against the IB disease alone. The 
effect of the previous infection of 8-week-old chicken with IBDV on 
their susceptibility to MS and Mycoplasma gallinaceum (MGn) then 
the antibody titers against MS and IBDV were detected by using HI 
and immune diffusion test [30]. Concomitant infection of MGn acts 
synergistically with MS and that previous exposure to IBDV increases 
the susceptibility of the synovial tissue to MS infection.
It was recorded that, birds infected with IBDV, that were later inoculated 
with MS (day 14), NDV (days 14 and 28), experienced an increased 
incidence and greater severity of airsacculitis than did chickens which 
were not exposed to IBDV [31]. Sarueng et al. [32] stated that severity 
of the respiratory disease resulting from infection by IBV is increased 
when there is co-infection with other infectious agents such as E. coli, 
MG and/or MS occurs. The present study recorded the protection 
percentage against IBDV revealing that all MG-infected IBD challenged 
groups showed higher protection percentage than the MG non-
infected IBD challenged group. IBD has been shown to interfere with 
the serological response to MS [31]. Reproduced synovitis in chickens 
was in groups challenged with both IBDV and MS, but not with MS 
alone [30].
Many previous studies [33-35] help to support the overall importance 
of the present results. Reo viruses have been shown to interact with MS 
in the production of synovitis. This virus neutralizing antibodies were 
detected in group infected with Reo virus together with the Mycoplasma, 
at 3 weeks and persisted until the end of the experiment at 15 weeks.
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CONCLUSION
The aim of this study was trying to explain the adverse effect of 
Mycoplasma on the titration and potency of viral vaccines, and the 
results revealed that MG infection could lead to false evaluation of these 
vaccines. The interaction between Mycoplasmas and viruses has been 
considered to be important not only in natural infection but also in 
vaccination process failure.
Compliance with ethics requirements
Chickens care as well as experimental protocols were incompliance 
with guidelines of ethical standards released by CLEVB on animal care 
and use. All efforts were made to minimize the numbers of animals 
and their suffering in this study through following the guidelines on 
laboratory animal care and use.
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